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Abstract
Background: Throughout history, syphilis has been a challenge to manage and control until the
invention of penicillin in 1943 was available. Even with effective treatment, the diagnosis and
clinical management of syphilis remains a challenge for providers. Purpose: The purpose of this
project was to increase provider knowledge of evidence-based practice in the clinical
management of syphilis, using public health detailing, to decrease inadequate and delayed
identification and treatment of syphilis. Methods: Providers from a federally qualified health
center (FQHC) participated in one public health detailing visit during March of 2021. Each
provider completed a Provider Practice Assessment, which looked at their knowledge, practice,
and attitudes in the clinical management of syphilis. Creation of an evidence-based Syphilis
Pocket Guide was utilized to promote knowledge translation. Quantitative data was entered into
Microsoft Excel and analyzed using descriptive statistics, such as frequency and percentages.
Results: A total of five providers participated in the public health detailing visit and completed
the Provider Practice Assessment. The results are consistent with the claim that providers
encounter challenges when managing patients with syphilis, with over 40% of providers selfrating their knowledge of syphilis staging as either fair or poor. Conclusion: Positive reception
and feedback of the public health detailing visits suggests they are successful strategies to
providing useful evidence-based practice education. Future recommendations include a more
robust, edited Provider Practice Assessment, a larger provider participant population, and
ongoing evaluation.
Keywords: syphilis, clinical management, provider practice, public health detailing

5
Use of Public Health Detailing to Improve Provider Practice
in the Clinical Management of Syphilis
Introduction
Syphilis is an infection caused by the bacterium Treponema pallidum (Center for Disease
Control and Prevention [CDC], 2017). It is transmitted sexually, and from mother to child, and
can invade any organ in the body (Nyatsanza & Tipple, 2016). Syphilis infection progresses
through different stages, which have unique clinical manifestations that can last weeks to years
(CDC, 2017; Forrestel et al., 2019). According to CDC (2018, p. ), “primary and secondary
syphilis are the earliest stages of infection, reflect symptomatic disease, and are indicators of
incident infection.” Dubbed “The Great Pretender”, signs and symptoms of early infection may
be overlooked or misdiagnosed by patients and providers, which can lead to increased morbidity
and transmission (CDC, 2017; Petrosky et al., 2016; Soreng, 2018).
After the invention of penicillin in 1943, the United States experienced a decline in the
number of cases for several decades, reaching a historic low of 5,979 cases (2.1 per 100,000) in
2000 (Clement et al., 2014; Forrestel et al., 2019). However, according to CDC sexually
transmitted disease (STD) surveillance data, the number of cases increased every year since, with
30,644 cases (9.5 per 100,000) reported in 2017 (CDC, 2018). Syphilis has reemerged as a
serious public health threat. In response to this growing epidemic and to prevent further
transmission, early detection and treatment is vital (Petrosky et al., 2016; Soreng, 2018).
Background
Diagnosis and management of patients with syphilis requires a thorough sexual history,
assessment of clinical presentation, and interpretation of serologic test results. The CDC (2005)
recommends providers assess their patient’s sexual history at their initial visit, when signs or
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symptoms of sexually transmitted infections (STI) are reported and during annual preventive
exams. Information obtained from a thorough sexual history identifies patient risk factors, guides
appropriate STI screening and frequency and creates an opportunity to discuss evidence-based
preventions, such as pre-exposure prophylaxis (PrEP). Despite the overwhelming benefits,
provider implementation and adherence remain a challenge, with many barriers reported (Barbee
et al., 2015; Chavez et al., 2018; Lanier et al., 2014).
Staging of syphilis is categorized according to clinical presentation and time since initial
infection, with stages often overlapping during the progression of the disease (Clement et al.,
2014). Early syphilis (primary, secondary, and non-primary non-secondary) is defined as syphilis
acquisition within the past 12 months, which is based upon the observation that infectivity
declines after the first year (Clement et al., 2014; Cohen et al.,2013). The first (primary) stage of
syphilis is marked by the appearance of chancre, typically indurated with raised borders, at the
site of inoculation, one week to three months (median=21 days) after exposure (CDC, 2018;
Cohen et al., 2014; Forrestel et al., 2019). Most often the chancre is painless, located on the
genitalia and will and heal in 3 to 6 weeks, regardless of treatment (Cohen et al., 2014; Forrestel
et al., 2019).
If primary syphilis is left untreated, the infection will progress to the secondary stage.
Secondary infection is associated with an onset of a rash on one or more areas of the body or
mucous membrane lesions (condyloma lata) in the anogenital region, two to eight weeks after the
disappearance of the chancre (CDC, 2018). According to Forrestel et al. (2019) systemic signs
and symptoms, such as fever, lymphadenopathy, and headache are often present; less frequently,
patients may have oral lesions or patchy “moth-eaten” hair loss. Early non-primary nonsecondary staging applies to individuals who are asymptomatic, with earliest date of exposure or
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infection determined to have occurred within the past year (Forrestel et al., 2019). According to
Clement et al. (2014), diagnosis of this stage is made when in the previous year an individual has
had one of the following: documented seroconversion or a ≥4-fold increase of a nontreponemal
titer, documented seroconversion of a treponemal test, or sexual exposure to a person with early
syphilis.
Unknown duration or late syphilis refers to infection (or reinfection) that lacks clinical
signs or symptoms, is accompanied with reactive serology and infection or exposure occurred
more than a year ago or is unknown (Clement et al., 2014; Forrestel et al., 2019)
The United States is currently experiencing a dramatic increase in syphilis incidence,
with the highest rates of reported primary and secondary cases in 2017 occurring in the West
(13.2 cases per 100,000) (CDC, 2018). In accordance with this trend, syphilis in Oregon has
reached epidemic levels (14 cases per 100,000), increasing over 1000% from 2008-2017 (Oregon
Health Authority [OHA], 2018). Consistent with previous years, early syphilis cases reported in
both Oregon and the rest of the U.S in 2017 occurred predominately among men who have sex
with men (MSM) (CDC, 2018; OHA, 2018). Parallel to increased rates of primary and secondary
syphilis among all women and women of reproductive age, rates of congenital syphilis have
steadily increased every year since 2012, with a 325% increase between 2013-2017 in the West.
(CDC, 2018). Oregon Health Authority (OHA) (OHA, 2019, p. 1) reported in their
Communicable Disease CD Summary “prior to 2014, Oregon averaged one congenital syphilis
every three years; since 2014 the numbers have been rising, with 10 cases reported in 2018.”
The CDC (2018) reports that 57.9% of all primary and secondary cases occurred among
men who have sex with men (MSM), with 52.1 % among men who have sex with men only and
5.8% among men who have sex with both men and women. Moreover, syphilis has also been
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associated with increased risk of HIV transmission and acquisition, with a high rate of HIV coinfection among primary and secondary cases (CDC, 2018; Holman et al., 2012; OHA, 2018;
Petrosky et al., 2016). In Oregon, OHA (2018) states that people living with HIV (PLWH)
account for half of all recent syphilis infections. Finally, CDC (2018) reported that among early
syphilis cases with known HIV status, 45.5% of cases among MSM were HIV-positive.
Syphilis is primarily acquired during sexual activities (anogenital, orogenital, and
vaginal) when an infectious lesion (chancre, condyloma lata, or mucous patch) is in contact with
an uninfected person’s mucous membrane or skin (Cohen et al., 2013; Forrestel et al., 2019).
According to Forrestel et al. (2019), risk of transmission after sexual exposure is estimated at
33%. In the context of increasing rates, now more than ever, it is important that providers
promptly and accurately diagnose and manage patients with syphilis.
Problem Statement
Diagnosis and clinical management of syphilis remains a challenge for providers. The
navigation of ambiguous staging, interpretation of serologic tests, obtaining a thorough sexual
history, treatment and follow-up contribute to these challenges. The purpose of this project was
to increase provider knowledge of evidence-based practice in the clinical management of syphilis
through public health detailing to decrease inadequate and delayed identification and treatment
of syphilis.
Organizational “Gap” Analysis of Project Site
In 2015, Washington County eliminated all clinic services, which included family
planning and STI clinics. Patients who received services at these clinics, especially those
considered high-risk, had to receive care elsewhere. Community providers, namely federally
qualified health centers (FQHCs), urgent care and emergency departments, were tasked with
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absorbing these clients. One of the driving factors associated with this shift was adoption of
Public Health Modernization, which focused on population rather than individual health. Instead
of providing services directly, focus on collaboration with community providers to ensure access
and care according to CDC recommendations was adopted.
Washington County Public Health has expanded in the past few years, with the
onboarding of an additional STI public health nurse and community health worker to meet the
growing need for case investigations. One of the primary goals of case investigations is to ensure
that patients (cases) and their contacts are treated appropriately and in a timely manner. This
provides an opportunity for provider education during case follow-up; however, an official
public health detailing program with an evidence-based action kit does not currently exist.
Review of the Literature
A comprehensive search of the literature for syphilis and clinical management, clinical
management and public health detailing was conducted on the following databases: PubMed of
the National Library of Medicine, Cumulative Index of Nursing and Allied Health Literature
(CINHAL) and Discovery Search. The Medical Subject Headings (MeSH) terms used were
syphilis for the PubMed search, in addition to terms clinical management, randomized and metaanalysis. For the search of CINHAL and Discovery Search, the following terms were used:
syphilis, clinical management, clinical practice, randomized controlled trial (RCT), metaanalysis, and public health detailing.
The search from the databases lists above yielded 68 articles, mostly reviews. Inclusion
criteria included full-text articles and articles that were published in the past five years. This left
six articles to review, in addition to six supplemental review articles to obtain the most recent,
evidence-based practice guidelines. The six articles that were reviewed for this project consisted
of one retrospective case study, one retrospective case-control study, one retrospective cohort
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study, one secondary analysis of data from a prospective, randomized trial, one experimental
cohort study and one descriptive study.
One of the main challenges that providers face when managing syphilis is the
interpretation of serologic results upon diagnosis and post-treatment. Treponema pallidum
cannot be cultured in a lab and providers must rely on indirect tests, which include treponemal
and nontreponemal tests (Tuddenham & Ghanem, 2015). In addition, two separate algorithms
are in used in the United States, the traditional and reverse screening algorithm (RSA). Recently,
more laboratories are implementing the use of the RSA, in which a treponemal test is used
initially, and if reactive is followed by a nontreponemal test. With these results a second
treponemal test is needed. If positive, this represents discordant results. According to
Tuddenham and Ghanem (2015), there are a few settings in which this could occur: early
primary syphilis, history of past treatment, a false positive result, the prozone phenomenon and
syphilis that has been untreated for a long time. Providers must then rely on their assessment and
chart review to determine the cause of the discordant results.
A review by Clement et al. (2017) evaluated the implementation of the RSA at a
Veteran’s facility and found that out of 160 patients who had discordant test results, only 26
(16.3%) had provider documentation of no previous treatment and an additional 60 (37.5%) had
unclear treatment histories. Moreover, of the 83 veterans who had no previous treatment, 37
(44.6%) received treatment and 46 (55.4%) did not have treatment documented after the test
results (Clement et al., 2017).
Another study that analyzed data from a prospective, randomized syphilis trial found an
association between stage of infection and baseline RPR titer was apparent in predicting
treatment response (Sena et al., 2011). “Serological cure was independently associated with
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young age, fewer sex partners in the past 6 months, earlier stage of infection, higher baseline
RPR titers, and a J-H reaction after treatment” (Sena et al., 2011, p. 1095).
One important piece to the clinical management of syphilis is a thorough sexual history
of the patient, especially when determining the stage and associated treatment regimen. In an
experimental cohort study, Lanier et al. (2014), which trained 26 physicians on sexual history
taking and then examined their integration into their practice, found four major themes. These
included the need for more training on how to take a sexual history, the significance of providing
a gender-neutral tool, numerous barriers exist for routine sexual history taking and HIV/STD
testing and inadvertent outcomes occurred for providers conducting sexual histories (Lanier et
al., 2014). Interventions recommended from this study included the need for improved, routine
provider-based sexual history trainings and the creation of clinical performance indicators to
track routine sexual history documentation and HIV/STD measures that could remind and
facilitate a dialogue between providers and their patients (Lanier et al., 2014).
A retrospective case study completed by Petrosky et al. (2016), examined possible gaps
in clinical management of early syphilis among men who have sex with men (MSM) in
Multnomah County, Oregon, found differences in treatment time of positive patients among
providers who worked at STD versus private clinics. Most patients who were diagnosed at the
STD clinic received same day treatment compared to a median time of three days for those who
were seen in a private practice. Additionally, almost a quarter of MSM with secondary syphilis
saw more than one provider with the same symptoms before being diagnosed. Finally, according
to Petrosky et al. (2016), providers in private practice may be less likely to take a sexual history
or recognize signs and symptoms of syphilis.
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Another intervention that has been reviewed and could be implemented in the clinical
management of syphilis is built-in reminders and systematic STI screenings in electronic health
record systems. Since patients with early syphilis may be asymptomatic, patients who are
considered at high risk should be screened more frequently. The CDC (2017) recommends that
providers perform a syphilis test on all sexually active MSM, including those who are HIV
positive annually and more frequently, such as every three to six months, if there are multiple
partners or substance abuse. With the implementation of an electronic patient record (EPR)
annual checklist for HIV-infected patients, Brook, et al. (2013) found routine screening
identified sex of 13 patients (46%) who were asymptomatic with syphilis infection. In addition,
they found that their systematic screening also increased the rate of STI diagnoses not only for
MSM, but also heterosexual patients.
Another study conducted by Bissessor et al. (2011) also found that a computer alert
increased the frequency of syphilis testing significantly among higher-risk MSM. As stated by
Bissessor et al. (2011, p.58), “The proportion of higher-risk men who received a diagnosis of
early syphilis and who were asymptomatic for syphilis increased from 16% (5 of 31 patients) to
53% (31 of 58).” Both studies represent an increase in both screening and detection of syphilis
when an alert or prompt is built into the patient’s electronic medical records and provide
evidence to support this intervention.
Public health detailing emerged from pharmaceutical detailing, where representatives
from pharmaceutical companies would visit provider offices to promote using their medications
over their competitors. According to Larson et al. (2006, p. 229), “utilizing the behavior change
strategies of pharmaceutical detailing, has proven effective in improving provider practices in
areas from diabetes and asthma to otitis media and acute bronchitis.” Specifically, for public
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health, detailing has been used successfully to promote increased HIV screening, judicious
opioid use and pre-exposure prophylaxis or PrEP prescribing. For example, Safi et al. (2017,
p.613) found that “74.4% of providers stated that their screening for HIV increased as a result of
the project and 62.2% of providers increased their readiness to test” after completion of their
detailing campaign. Additionally, success with the use of public health detailing to promote the
use of PrEP among providers was so successful, it has been implemented in New York City,
New England, and elsewhere (Ard et al., 2018).
Public health detailing and the utilization of toolkits can support knowledge translation
(KT), connecting research to practice. A range of evidence-based KT strategies have been
employed and include printed educational materials, educational meetings, educational outreach,
audit and feedback, and reminders (Barac et al., 2014; Yamada et al., 2015). According to
Yamada et al. (2015), “these strategies have been used alone as single KT intervention or as
multifaceted KT interventions, which consist of two or more strategies or variations of the same
strategies (e.g., educational materials) delivered in combination to change practice.” A toolkit,
which can be defined as multiple resources or tools that codify explicit knowledge (templates,
pocket card guidelines, algorithms) and are applied to share knowledge and educate and/or
facilitate behavior change (Barac et al., 2014; Yamada et al., 2015).
Evidence Based Practice Intervention
The planned intervention used public health detailing to implement provider education, to
those who have seen syphilis cases in the community, on evidence-based practice in the clinic
management of syphilis.
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Theoretical Framework
The theoretical framework used to guide this DNP project is Kurt Lewin’s Theory of
Planned Change (TPC). According to Galli (2018), Lewin identified three assumptions for
effective change: a change motivator must be present, employees are at the center of the changes
within an organization, and individuals who are affected by the change need to adapt and include
the new changes into their routine, thus discontinuing their past practices. Prior to initiating the
three phases of change, which include unfreezing, movement and refreezing, Lewin developed
force field analysis (FFA). Force field analysis is the framework that provides the foundation for
TPC. “An FFA specifies forces as either driving (helping forces) or restraining (hindering forces)
movement toward a goal” (Shirley, 2013, p. 69). A diagram of this framework is included in the
appendix (see Appendix A).
The first phase of TPC is unfreezing, which entails identifying a problem, recognizing the
need for change and then mobilizing others to also see the need for change. Providers are
encountering difficulties with the clinic management of syphilis. In the context of increasing
rates of syphilis, there is a need for increased provider education and adoption of evidence-based
practices. Acknowledgement of the need to incorporate best practices when managing patients
with syphilis is critical. Additionally, a sense of urgency to change is also part of this phase. For
example, delayed identification and treatment of patients who present with early syphilis, not
only can lead to long-term individual sequelae, but also impact the health of the community in
which they practice. Identifying helping and hindering forces is essential. For this project,
surveying providers on their current practice and barriers they encounter to providing evidencebased care helps identify solutions and needed behavior changes.
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Movement is the second phase of TPC. This phase consists of trial and error around new
practices and norms. As Shirley (2013, p. 70) states, “this stage necessitates creating a detailed
plan of action and engaging people to try out the proposed change.” This project used public
health detailing to operationalize the behavior change (e.g., taking a thorough sexual history,
staging appropriately, etc.) that providers must make.
The last phase is known as refreezing, in which change is stabilized and becomes rooted
into systems such as culture, practice and policies. As providers use evidence-based practice to
clinically manage patients with syphilis, it becomes more routine to take a sex history, or a new
policy on using the reverse testing algorithm might be incorporated. For these practice changes
to be sustainable, these changes must be embedded in both the individual provider practice and
clinic levels.
Methods
Goals and Objectives
The goal of this DNP project was to increase provider awareness and implementation of
evidence-based practice in the clinical management of syphilis through public health detailing
visits and distribution of action kits. Additional goals of this project included provider
appreciation of local epidemiological data, evaluation of the provider pocket guide, and
improved collaboration between Washington County Disease Control and Prevention and
community providers.
Objectives
•

Completion of at least two visits to each provider over the course of a 12-week period

•

Distribution of action kits to 30 providers by the end of the 12-week period

•

Completion of a pre- and post-provider assessment by 30 providers
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Outcomes
•

Adoption of at least one evidence-based practice change by each provider by the end of
the 12-week period

•

Increase in provider self-reported knowledge of syphilis staging and treatment or syphilis
labs and interpretation by one point on the Likert scale by the end of the 12-week period.

Project Site and Population
This project took place in Washington County, Oregon, part of the Portland Metro region,
which also includes Multnomah and Clackamas counties in Oregon and Clark County in
Washington. In 2015, Washington County eliminated all clinic services, which included family
planning and STI clinics. Sites of public health detailing were chosen based upon current
epidemiological data collected from the Orpheus, the Oregon Public Health Epi User System.
This system is used by local health departments (LHDs) when completing investigations of
reportable communicable disease. Criteria for selection included sites that have diagnosed a
syphilis case or have requested assistance from the LHD in the clinical management of a case,
including treatment, in the past year.
Public Health Detailing Visits
According to Kattan et al. (2016, p. 1430), “public health detailing campaigns are
focused on specific clinical topics, emphasize a limited number of key messages, and offer
practice tools, provider information, and patient education resources at the one-on-one visits.”
The first visit included the following: action kit was be dispersed, assessment of current practice,
syphilis overview with epidemiological data, review of key messages/strategies, commitment to
one action item. The second visit included reinforcement of key messages, and during the last
visit, the assessment will be re-administered to assess for practice change.
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An evidence-based provider pocket guide was developed as part of the action kit. Barac
et al. (2014) reviewed the use of toolkits in health and healthcare and found that the type of
evidence underlying the development was wide-ranging. The type of evidence that was found
included literature reviews, evidence-based guidelines, expert panels, qualitative data (interviews
or stakeholder surveys), and less frequently, best-practice approaches and observations of
existing practices (Barac et al., 2014).
The provider pocket guide that was developed and used for this project incorporated
evidence from a literature review, evidence-based guidelines and algorithms, best-practice
approaches, and review with feedback from local and state subject matter expert colleagues.
Additionally, observed trends of knowledge gaps in existing provider practice was also
considered in the toolkit development. The flow of the provider pocket guide was meant to align
with a best-practice STI clinical visit, starting with a thorough sexual health history. According
to the CDC’s Guide to Taking a Sexual History, “a sexual history should be taken as part of
routine health care, as well as when there are symptoms or physical exam findings of STIs”
(CDC, 2022, p.). Questions such as does the patient have a history of any STIs, what symptoms
are reported by the patient, what is found on their physical exam, and are they a recent contact to
someone who was recently diagnosed with an STI will help guide their assessment/plan.
Knowing what syphilis tests to order and how to interpret them is the next part of the
provider pocket guide. Incorporating the two syphilis algorithms into the pocket guide was to
help providers walk through the ordering and syphilis testing cascade, regardless of which
algorithm their lab used. Additionally, a syphilis titer chart displayed the difference between a
two-fold and four-fold increase/decrease lab result. This is critical when determining if a new
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infection is present in a patient who has had a previous syphilis infection, and when evaluating
response to treatment.
Syphilis staging is the evaluation of clinical presentation, sexual history, and lab results.
This is important because the syphilis stage will determine the treatment plan. Patients who are
staged as having early syphilis (primary, secondary, or non-primary/non-secondary) should
receive one dose of benzathine penicillin G, compared to those with late syphilis, who need three
doses of benzathine penicillin G. A staging algorithm was added to the pocket guide to help the
provider appropriately stage and treat the patient accordingly. Follow-up testing and evaluation
relies on interpretation of the patient’s syphilis titer.
When developing the provider pocket guide, additional information on extra genital
chlamydia/gonorrhea screening and treatment were included for a comprehensive tool (see
Appendix B).
Action kits were handed out to the providers at the first detailing visit and included the
following: a provider pocket guide, posters (visual for self-collected swabs), and patient
education materials (see Appendix C).
Measurement Instruments
To measure the outcomes of this DNP project, the following instruments were used: a
Detailing Log (see Appendix D) and Provider Practice Assessment (see Appendix E) for each
provider. A numerical code was assigned for each type of provider and practice to protect their
identity. The detailing log included information on provider training, years in practice, practice
setting, time spend with each provider and site location. In addition, one Likert scale item was
used to assess how well the detailing visit was received. A provider practice assessment, a 15item survey, collected information on current practice at the first and practice changes at the last
visit. Clinical practice information included sexual history taking, lab ordering and interpretation,
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syphilis staging and treatment, and any barriers that the provider as encountered. These tools
were developed in collaboration with the site mentor.
Data Collection Procedures
Quantitative and qualitative data were collected at the first and last visit (see Appendix C
and D). During the first visit, information was collected on the detailing log and entered on an
Excel spreadsheet. Provider assessments were administered during the initial visit and last visit.
The data collected from the provider assessments were entered in Microsoft Excel for analysis.
Informal, unstructured face-to-face conversations with providers, direct observations, field notes
and written quotes were also collected.
Data Analysis
Quantitative data was analyzed using descriptive statistics, such as frequency and
percentages. Qualitative information obtained during the project was compiled and summarized
to identify common themes.
Ethical Considerations/Protection of Human Subjects
The University of Massachusetts, Amherst (UMass) Internal Review Board (IRB)
approval was obtained prior to initiating the DNP Project (see Appendix F). Information
collected did not include any patient health information (PHI), thus eliminating any direct risk to
human subjects. Provider identity was protected by assigning codes and files were stored on a
password protected computer.
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Results
This project was implemented during the month of March 2021 and was entirely online
due to the COVID pandemic. A total of five providers, from a locally qualified health center
(FQHC) in Washington County, participated via a Microsoft Teams meeting. Demographic
characteristics of the providers are described below in Table 1.
Table 1
Provider Characteristics
Count

Percentage

3
1
1
5

60
20
20
100

0
2
2
1
5

0
40
40
20
100

Type of provider
Nurse Practitioner
Medical Doctor
Physician Assistant
Total
Years in practice
0-2
3-6
7-9
More than 10
Total

Over half, 60% (n=3), were nurse practitioners, and all providers had at least 3 years of
experience. A provider practice assessment was used to evaluate the provider’s self-reported
knowledge, practice, and attitudes. First, providers were asked when they take a sexual health
history, and how they would rate their sexual history taking skills. See Table 2. Eighty percent
(80%, n=4) of providers reported taking a sexual health history as part of an annual or wellness
visit and if warranted during a problem focused visit. However, when asked how they would rate
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their sexual history taking skills, the answers varied. Over half, 60% (n=3), rated themselves as
either excellent or good.
Table 2
Sexual Health History
Count

Percentage

0
1

0
20

0
4

0
80

5

100

1
2
1
1
0
5

20
40
20
20
0
100

When do you take a sexual health history?
I have never taken a sexual health history
I only take a sexual health history during problem-focused
visits
I take a sexual history as part of an annual or wellness visit
I take a sexual history as part of an annual or wellness visit
and if warranted during a problem-focused visit
Total
How would you rate your sexual history taking skills?
Excellent
Good
Neutral
Fair
Poor
Total

Providers were then asked about their practice regarding syphilis lab ordering and
interpretation (See Table 3).
Table 3
Syphilis Lab Ordering and Interpretation
Count
Do you know which syphilis screening algorithm
your lab uses?

Percentages
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Reverse
Traditional
Unknown
Total

2
0
3
5

40
0
60
100

1
0
3
1
5

20
0
60
20
100

2
0
3
0
5

40
0
60
0
100

When you screen for syphilis, which test(s) do you
order?
RPR
Treponemal EIA/CIA
Both
Depends on patient’s history
Total
How would your rate your knowledge of syphilis
labs and interpretation?
Excellent
Good
Neutral
Fair
Poor
Total

Over half, 60% (n=3), of the providers did not know which syphilis screening algorithm
their labs use. When asked which test(s) they order for syphilis, 60% (n=3) reported ordering
both RPR and Treponemal EIA/CIA tests, with only one provider stating it depends on the
patient’s history. Regarding self-reported knowledge of syphilis labs and interpretation, it was
divided, with 40% (n=2) of providers answering good versus 60% (n=3) answering fair.
Next, they were asked to rate their knowledge of syphilis staging and treatment. Another
question assessed if they presumptively treat patients who have clinical signs/or symptoms of
syphilis or if they wait for test results. See Table 4 below.
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Table 4
Syphilis Staging and Treatment
Count

Percent

0
3
1
1
5

0
60
20
20
100

I presumptively treat for syphilis if my patient has
clinical signs/or symptoms of early syphilis

3

60

I wait for serologic test results before I treat my
patient, regardless of clinical signs/or symptoms

2

40

Total

5

100

How would you rate your knowledge of syphilis
staging and treatment?
Excellent
Good
Neutral
Fair
Poor
Total

How would you best describe your treatment
practice for syphilis?

Interestingly, self-reported knowledge of syphilis staging, and treatment was low, with
40% (n=2) of providers stating they were either fair or poor. However, over half, 60% (n=3),
reported that they presumptively treat patients who present with clinical signs/ or symptoms.
Last, the providers were asked what their biggest challenge is when managing patients with
syphilis. Two providers reported syphilis staging, one reported clinical presentation, one reported
follow-up testing, and the last provider reported other: distinguishing between old versus new
infections. All providers stated that their practice carried benzathine penicillin G for syphilis
treatment, and that they do not refer patients out for treatment.
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After reviewing the provider pocket guide, providers were asked to provide any feedback.
All providers stated that the pocket guide was helpful, with the information being clear, concise,
and useful. Only one provider stated that they “just need to know what test to order and to take
out the algorithm.”
Discussion
This project focused on improving provider awareness and practice in the clinical
management of syphilis using public health detailing and the development of an evidence-based
action kit. A total of five providers participated in one public health detailing visit and
completed the Provider Practice Assessment. The results are consistent with the claim that
providers encounter challenges when managing patients with syphilis. According to Clement et
al. (2014), syphilis serology is used in both the diagnosis and assessment of treatment response.
Considering the significance, when asked to rate their self-reported knowledge of syphilis labs
and interpretation, only 40% answered good versus 60% answering fair. Moreover, 40% of
providers rated their knowledge of syphilis staging and treatment as either fair or poor.
Positive reception and feedback of the public health detailing visits suggests they are
successful strategies to providing useful evidence-based practice education. Finally, this project
strengthened the collaboration between public health and the providers who participated. By
meeting “face to face”, this allowed for formal introductions, discussions regarding resources
that public health can offer to providers, and a commitment to ongoing partnership.
There are several future recommendations based on the project findings, engaging a
larger provider population from a variety of clinic settings, verifying the providers’ perceptions,
and revising the Provider Practice Assessment. This project included five providers from one
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FQHC. Although the project was successful, it is imperative to expand and evaluate the
effectiveness among a larger provider population.
Moreover, after implementing the Provider Practice Assessment, it could be further
refined. For example, in addition to asking the provider when and how they would self- rate their
sexual history taking skills, asking them what specific questions, or set of questions are used, and
how it is administered (patient filling out a sexual history assessment on paper or electronically,
an MA reviewing it with the patient, etc.) is suggested. Two questions which asked the providers
to self-rate their knowledge of syphilis labs and interpretation, and syphilis staging, and
treatment should be separated into four questions, assessing syphilis lab ordering, lab
interpretation, staging, and treatment individually. This would allow for a more comprehensive
assessment and highlight gaps in knowledge and areas for improvement in finer detail. Finally,
the addition of questions that assess the following: what resources (Apps, guidelines, provider
consultations, health department, etc.) are used when challenges or questions in clinical
management arise; when pregnancy status is evaluated, are providers assessing for neurosyphilis
signs and symptoms (if so, how and when; what referral process(s) are in practice for patients
who may have neurosyphilis, including additional diagnostics, specialty consultations, and
treatment.
Facilitators of this project included an already established relationship between the
FQHC and Washington County Public Health. All providers who participated were enthusiastic
to participate and eager to learn. Additional facilitators of this project include ongoing
leadership support at Washington County Public Health and assistance of the Washington
County graphic designer on the Syphilis Pocket Guide.
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Due to the COVID pandemic, the scale of the project had to be scaled down. Instead of
implementing the project at multiple sites, only one site was selected. In addition, due to the
limited availability of the providers, one visit was completed per provider via a Microsoft Teams
meeting. The development of the provider pocket guide took much longer than expected. The
content was reviewed by internal and external colleagues for feedback prior to implementation
and underwent a few edits. Because the project was done entirely online, action kits were not
distributed during the project implementation. Rather, they will be distributed after incorporating
the feedback from the providers who participated in this project.
Results of this project and the final provider pocket guide will be presented this summer
at our Quad County Meeting, which gathers public health nurses, disease intervention specialists
(DIS), and management of four local health departments in the Portland Metro area.
Additionally, further action includes the continuation of provider education using public health
detailing and the action kits, expanding to other providers and clinics in Washington County.
Conclusion
In the context of increasing syphilis rates in the United States, now more than ever, it is
important that providers are adequately screening, diagnosing, and managing syphilis patients.
The literature supports assessment of challenges providers encounter and implementation of
interventions that promote evidence-based practice, such as lab ordering and interpretation,
syphilis staging, treatment, and follow-up monitoring. This project concentrated on these
challenges using public health detailing and the creation of a Syphilis Pocket Guide to improve
provider practice in the clinical management of syphilis.
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Future recommendations include a more robust, edited Provider Practice Assessment that
can be entered into a software program, such as Qualtrics, which includes skip logic and data
analysis features. Additionally, a larger population size would allow for more complex data
analysis and evaluation, with the potential for generalizable data and interventions. Another way
of providing greater accessibility to the Syphilis Pocket Guide would be to create a smart App, in
which a provider may enter clinical information (labs, clinical presentation, etc.) that would walk
them through the algorithms and provide tailored guidance for a specific patient.
Evidence-based practice in the clinical management of syphilis is imperative. As the
number of cases continue to rise each year, interventions that provide education and guidance
will continue to be a valuable tool. Use of public health detailing, with the distribution of action
kits and a Syphilis Pocket Guide can be utilized as a tool to support knowledge translation.
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Appendix A
Lewin’s (1951) Change Model

Mitchell, Gary. (2013). Selecting the best way to implement change. Nursing Management-UK,
20, 32-37. Retrieved from
http://home.nwciowa.edu/publicdownload/Nursing%20Department%5CNUR310%5CSel
ecting%20the%20Best%20Theory%20to%20Implement%20Planned%20Change.pdf
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Appendix B
Syphilis Pocket Guide

Syphilis
Pocket Guide
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CLINICIAN
REPORTING LINE
Phone: 503-846-3594
Fax: 503-846-3644
Urgent After-Hours Phone: 503-276-7795

*Please let your patients know the Health
Department will be following up with them*

Disease Control and Prevention Program
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Your patients’ sexual history is an important part of their
overall health and wellness. Taking a sexual history will help
guide the physical exam, screening of all exposed sites
for sexually transmitted infections (STI) and establish your
patients’ STI/HIV risk. Take a sexual history from all patients.
THE 5P’S OF SEXUAL HEALTH

1
2
3
4
5

PARTNERS: Number and gender of partners over
a given time.
PRACTICES: Types of sexual practices –
oral, vaginal, anal.
PROTECTION FROM STIS: Use of condoms and
other methods.
PAST HISTORY OF STIS: Establish risk of repeat
infections, HIV status and hepatitis risk.
PREVENTION OF PREGNANCY: Desire of pregnancy
and use of prevention methods.

BEST PRACTICES FOR OBTAINING A SEXUAL HISTORY
◼ Ensure a safe patient environment
◼ Assure confidentiality
◼ Be non-judgmental
◼ Be sensitive and matter-of-fact
◼ Avoid assumptions
◼ Take a sexual history from all patients
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EXTRAGENITAL SCREENING FOR
GONORRHEA AND CHLAMYDIA

Testing for GC/CT at any site other than the urethra, vagina,
WHAT
or cervix
◼

◼

◼

Includes testing in the rectum and throat, based on patientreported exposure
In May 2019, the FDA cleared two NAATs for extragenital
testing
◼ Aptima Combo 2 Assay
◼ Xpert CT/NG

ong men who have sex with men (MSM)
WHAmY
Nearly 90% of rectal GC and CT infections are asymptomatic
◼

◼

Urine only screening would miss 77% of rectal CT and 95%
of GC infections
◼ Rectal infection is linked to an increased risk of HIV infection
Among women, 30% of GC and 14% of CT infections would
have been missed with urogenital testing only

◼

◼

ectal
WHRO
The patient (any gender) has had receptive anal intercourse
◼

◼

◼

with a male in the past year, regardless of condom use
Throat
◼ The patient (any gender) had oral intercourse within the
past year

pecimens can be clinician or self-collected
HOSSelf-collection,
W
especially for rectal specimens, increases the
◼

◼

uptake of testing
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GONORRHEA AND
CHLAMYDIA TREATMENT
CHLAMYDIA
Uncomplicated urogenital/oral infections
◼ Azithromycin 1 gram PO in a single dose
Uncomplicated rectal infections
◼ Doxycycline 100 mg PO BID x 7 days* or
◼ Azithromycin 1 gram PO in a single dose
* Recent research suggests that doxycycline may be more effective than azithromycin
for rectal CT and can be considered first-line therapy for this infection

GONORRHEA
Uncomplicated cervix/urethra/oral/rectal infections
Dual therapy is no longer recommended
o Ceftriaxone 500 mg IM x 1
◼

o
◼

For people weighing > 150 kg (300 lb)
ceftriaxone 1gram IM x 1

If chlamydia cannot be ruled out: ceftriaxone
(based on weight) PLUS doxycycline 100 mg
po BID x 7 days
During pregnancy, azithromycin 1gram po
should be used
For those allergic to ceftriaxone: gentamicin 240 mg IM x
1 PLUS azithromycin 2 grams po x 1
o

◼

EXPEDITED PARTNER THERAPY (EPT)
Expedited partner therapy (EPT)
o
o

Cefixime 800 mg PO x 1 only
If chlamydia cannot be ruled out in the partner:
cefixime 800 mg PO x1 PLUS doxycycline 100
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TREATING PARTNERS
◼ Recent sex partners (i.e., persons having sexual contact
with the infected patient within the 60 days preceding onset
of symptoms or gonorrhea diagnosis) should be referred for
evaluation, testing, and presumptive treatment.
◼

If you are unable to locate or treat partner(s), please call the
Washington County Disease Control and Prevention Program
503-846-3594

ADDITIONAL RECOMMENDATIONS

◼

◼

For people with pharyngeal gonorrhea: test-of-cure is
recommended 7-14 days after treatment regardless of treatment
regimen
Repeat testing is recommended 3 months after treatment of
gonorrhea infection (any site)
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DILUTIONS OF
NON-SPECIFIC TESTS
(RPR/VDRL)
1:1024
1:512
1:256
1:128

2 dilution or
“4 fold”

1:64
1:32
1:16
1:8
1:4
1:2
1:1

1 dilution or
“2 fold”
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Appendix C
Action Kit Outline
Provider pocket guide
•
•
•
•
•
•
•

How to take a sexual health history
Syphilis serologic screening algorithms
o Reverse and traditional
Dilutions of non-treponemal (RPR/VDRL) tests
Congenital syphilis screening and treatment
Syphilis staging algorithm
Syphilis treatment recommendations
o Treating partners
o Follow-up and monitoring
Extragenital testing recommendations for chlamydia and gonorrhea

Posters
•
•
•

Oregon Public Health Division Reporting for Clinicians
Poster with visualization of correct swabs to use
The Visual Guide for a Self-collected Swab
o Rectal Swab-English
o Rectal Swab-Spanish
o Pharyngeal Swab-English
o Pharyngeal Swab-Spanish
o Vaginal Swab-English
o Vaginal Swab-Spanish

Additional Materials
•
•
•

Pens
Handout on penicillin allergies
Washington County Disease Control and Prevention (DCAP) reporting forms
o Chlamydia and gonorrhea
o Syphilis
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Appendix D
Detailing Log

1). Encounter Date______________________________________________
2). Type of Provider (MD, DO, NP, PA, ND) _____________________________
3). Time spent with provider/clinic
staff_______________________________________________________
4). Practice Setting
o
o
o
o
o

Private Practice
Hospital Based Primary Care Clinic
Urgent Care
FQHC
Other

5). Clinic Name_________________________________________________
6). Clinic Address____________________________________________________
7). Number of years in practice___________________________________________
8). Where does the provider appear to be on the enthusiasm spectrum?

1□ 2□ 3□ 4□ 5□
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Appendix E
Provider Practice Assessment

1). When do you take a sexual history?
o I have never taken a sexual history
o I only take a sexual history during problem-focused visit (i.e. when there is concern about
risk or a sexually transmitted infection)
o I take a sexual history as part of an annual or wellness visit
o I take a sexual history as part of an annual/wellness visits and if warranted during a
problem-focused visit
2). What are the reasons why you have never taken a sexual history? (Check all that apply)
o
o
o
o
o
o

Time
Not reimbursable by insurance
Staff are not supportive
Patients don’t want to talk about sex
Comfort or training in asking sexual health questions
Other__________________________

3). What are the reasons why you only take a sexual history as part of a problem-focused visit?
(Check all that apply)
o
o
o
o
o
o

Time
Not reimbursable by insurance
Staff are not supportive
Patients don’t want to talk about sex
Comfort or training in asking sexual health questions
Other__________________________

4). What are the reasons why you only take a sexual history as part of an annual/wellness visit?
(Check all that apply)
o
o
o
o
o
o

Time
Not reimbursable by insurance
Staff are not supportive
Patients don’t want to talk about sex
Comfort or training in asking sexual health questions
Other__________________________
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5). How would you rate your sexual history taking skills?
o
o
o
o
o

Excellent
Good
Neutral
Fair
Poor

4). When do you order a STI test? (Check all that apply)
o
o
o
o
o

I do not test for STI’s
When patients are symptomatic
When patients request screening
As part of a routine annual/wellness visit
Other__________________________________

5). Which STI tests do you routinely order?
o
o
o
o
o

CT/GC (genital)
CT/GC (extra-genital)
Syphilis
HIV
Other____________________________________

6). What are the reasons why you do not order extra-genital CT/GC tests? (Check all that apply)
o
o
o
o
o
o
o

I was am not aware or familiar with extra-genital CT/GC testing
Time
My staff are not trained
My practice does not support it
Not reimbursable by insurance
My practice does not carry the correct swabs for collection
Other___________________________________

7). Do you know which syphilis screening algorithm your lab uses?
o Reverse
o Traditional
o Unknown
8). When you screen for syphilis, which test(s) do you order?
o
o
o
o

RPR
Treponemal EIA/CIA
Both
Depends on patient’s history
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9). How would you rate your knowledge of syphilis labs and interpretation?
o
o
o
o
o

Excellent
Good
Neutral
Fair
Poor

9). How many patients have you seen with syphilis in the last 12 months?
o
o
o
o

0
1
2-3
3+

10). How would you rate your knowledge of syphilis staging and treatment?
o
o
o
o
o

Excellent
Good
Neutral
Fair
Poor

11). How would you best describe your treatment practice for syphilis?
o I presumptively treat for syphilis if my patient has clinical signs/or symptoms of early
syphilis
o I wait for serologic test results before I treat my patient, regardless of clinical sign/or
symptoms
11). Does your practice carry benzathine penicillin G?
o Yes
o No
12). If no, where do you refer patients for treatment of syphilis?
o
o
o
o
o

Patient’s PCP
Urgent Care/ED
Safety net provider/FQHC
Washington County Public Health
Other______________________________________________

13). Have you encountered any barriers to treating syphilis in your practice?
o No
o Yes
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14). If yes, what barriers?
o
o
o
o
o
o

I have never treated a patient with syphilis
Time
Not reimbursable by insurance
Recommended treatment not available at my practice
Unsure how to best treat complicated cases
Other_____________________________________________

15). What is the biggest challenge for you when managing patients with syphilis?
o
o
o
o
o
o

Clinical presentation
Lab ordering/interpretation
Syphilis staging
Syphilis treatment
Follow-up testing
Other______________________________________________
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Appendix F
Human Subjects Research Determination

